Nerve growth factor-β expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma

World Journal of Surgery

Volumn 34, Issue 5, 2010, Pages 1039-1045

  Xu, Lei Bo ^a   Liu, Chao ^a   Gao, Guo Quan ^b   Yu, Xian Huan ^a   Zhang, Rui ^a   Wang, Jie ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BIOSYNTHESIS; CANCER INVASION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PERIPHERAL NERVE TUMOR;

ADULT; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NERVE GROWTH FACTOR; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 77954707349     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0417-4     Document Type: Article

References (40)

1. Tsao JI, Nimura Y, Kamiya J et al (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232:166-174
2. Jemal A, Thomas A, Murray T et al (2002) Cancer statistics. CA Cancer J Clin 52:181-182
3. Cristofanilli M, Charnsangavej C, Hortobagyi G (2002) Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 1:415-426
4. Scavelli C, Vacca A, Di Pietro G et al (2004) Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 18:1054-1058
5. Liang D, Chang J, Chin A et al (2001) The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech Dev 108:29-43
6. Hirakawa S, Brown L, Kodama S et al (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010-1017
7. McCarter MD, Clarke JH, Harken AH (2004) Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery 135:121-124
8. Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413-423
9. Stacker SA, Baldwin ME, Achen MG (2002) The role of tumor lymphangiogenesis in metastatic spread. FASEB J 16: 922-934
10. Choi WWL, Lewis MM, Lawson D et al (2005) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 18:143-152
11. Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255-1257
12. Descamps S, Pawlowski V, Revillion F et al (2001) Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res 61:4337-4340
13. Sortino MA, Condorelli F, Vancheri C et al (2000) Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors. Mol Endocrinol 14:124-136
14. Tokusashi Y, Asai K, Tamakawa S et al (2005) Expression of NGF in hepatocellular carcinoma cells with its receptors in nontumor cell components. Int J Cancer 114:39-45
15. Ma J, Jiang YM, Jiang YH et al (2008) Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 23:1852-1859
16. Lazarovici P, Marcinkiewicz C, Lelkes PI (2006) Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharma Des 12:2609-2622
17. American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, New York, pp 145-149
18. Su JL, Shih JY, Yen ML et al (2004) Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel-mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res 64:554-564
19. Weidner N (1995) Current pathological methods for measuring intratumoral microvessel density within breast-carcinoma and other solid tumors. Breast Cancer Res Treat 36:169-180
20. Shaib Y, El-Serag H (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-125
21. Patel T (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33:1353-1357
22. Khan S, Taylor-Robinson S, Toledano M et al (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806-813
23. Shimada K, Sano T, Sakamoto Y et al (2005) Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J Surg 29:723-727
24. Wigle JT, Harvey N, Detmar M et al (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21:1505-1513 (Pubitemid 34614607)
25. Jackson D, Prevo R, Clasper S et al (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22:317-321
26. Mobius C, Freire J, Becker I et al (2007) VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus. World J Surg 31:1768-1774
27. Shida A, Fujioka S, Ishibashi Y et al (2005) Prognostic significance of vascular endothelial growth factor D in gastric carcinoma. World J Surg 29:1600-1607
28. Gu Y, Qi XL, Guo SY (2008) Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis 25:717-725
29. Jeltsch M, Kaipainen A, Joukov V et al (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425
30. Thelen A, Scholz A, Benckert C et al (2008) Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol 15: 791-799
31. Saito Y, Nakagami H, Morishita R et al (2006) Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 114:1177-1184
32. Shin JW, Min M, Larrieu-Lahargue F et al (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17:576-584
33. Bernabei R, Landi F, Bonini S et al (1999) Effect of topical application of nerve-growth factor on pressure ulcers. Lancet 354:307
34. Tuveri M, Generini S, Matucci-Cerinic M et al (2000) NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 356:1739-1740
35. Cantarella G, Lempereur L, Presta M et al (2002) Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16:1307-1309
36. Raychaudhuri SK, Raychaudhuri SP, Weltman H et al (2001) Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch Dermatol Res 293:291-295
37. Graiani G, Emanueli C, Desortes E et al (2004) Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia 47:1047-1054
38. Park HJ, Kim MN, Kim JG et al (2007) Up-regulation of VEGF expression by NGF that enhances reparative angiogenesis during thymic regeneration in adult rat. Biochim Biophys Acta Mol Cell Res 1773:1462-1472
39. Tammela T, Enholm B, Alitalo K et al (2005) The biology of vascular endothelial growth factors. Cardiovasc Res 65:550-563
40. Cao RH, Bjorndahl MA, Religa P et al (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6:333-345